SETH LERNER to Feasibility Studies
This is a "connection" page, showing publications SETH LERNER has written about Feasibility Studies.
Connection Strength
0.047
-
Adenovirus-mediated suicide gene therapy for experimental bladder cancer. Urology. 1997 Feb; 49(2):173-80.
Score: 0.025
-
Neoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activity. Urol Oncol. 2016 Jan; 34(1):4.e11-7.
Score: 0.023